Literature DB >> 33874963

Regulation of circulating CTRP-2/CTRP-9 and GDF-8/GDF-15 by intralipids and insulin in healthy control and polycystic ovary syndrome women following chronic exercise training.

Jayakumar Jerobin1, Manjunath Ramanjaneya2, Ilham Bettahi2, Raihanath Parammal2, Kodappully Sivaraman Siveen3, Meis Alkasem2, Myint Aye4, Thozhukat Sathyapalan4, Monica Skarulis2, Stephen L Atkin5, Abdul Badi Abou-Samra2.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity, diabetes, and insulin resistance. The circulating C1Q/TNF-related proteins (CTRP-2, CTRP-9) and growth differentiation factors (GDF-8, GDF-15) contribute to glucose and lipid homeostasis. The effects of intralipids and insulin infusion on CTRP-2, CTRP-9, GDF-8 and GDF-15 in PCOS and control subjects before and after chronic exercise training were examined.
METHODS: Ten PCOS and nine healthy subjects were studied at baseline status and after moderate-intensity chronic exercise training (1 h exercise, 3 times per week, 8 weeks). All participants were infused with 1.5 mL/min of saline or intralipids (20%) for 5 h, and during the last 2 h of saline or intralipids infusion hyperinsulinemic-euglycemic clamp (HIEC) was performed. CTRP-2, CTRP-9, GDF-8 and GDF-15 levels were measured at 0, 3 and 5 h.
RESULTS: Intralipids dramatically increased CTRP-2 levels in PCOS (P = 0.02) and control (P = 0.004) subjects, which was not affected by insulin infusion or by exercise. Intralipids alone had no effects on CTRP-9, GDF-8, or GDF-15. Insulin increased the levels of GDF-15 in control subjects (P = 0.05) during the saline study and in PCOS subjects (P = 0.04) during the intralipid infusion. Insulin suppressed CTRP9 levels during the intralipid study in both PCOS (P = 0.04) and control (P = 0.01) subjects. Exercise significantly reduced fasting GDF-8 levels in PCOS (P = 0.03) and control (P = 0.04) subjects; however, intralipids infusion after chronic exercise training increased GDF-8 levels in both PCOS (P = 0.003) and control (P = 0.05) subjects and insulin infusion during intralipid infusion reduced the rise of GDF-8 levels.
CONCLUSION: This study showed that exogenous lipids modulate CTRP-2, which might have a physiological role in lipid metabolism. Since chronic exercise training reduced fasting GDF-8 levels; GDF-8 might have a role in humoral adaptation to exercise. GDF-15 and CTRP-9 levels are responsive to insulin, and thus they may play a role in insulin responses.

Entities:  

Keywords:  C1Q/TNF related proteins; Euglycemic clamp; Exercise and polycystic ovary syndrome; Growth differentiation factors; Insulin; Insulin resistance; Lipid

Year:  2021        PMID: 33874963     DOI: 10.1186/s12944-021-01463-3

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


  38 in total

1.  Obesity and Polycystic Ovary Syndrome.

Authors:  Susan Sam
Journal:  Obes Manag       Date:  2007-04

2.  Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance.

Authors:  Yanjun Jia; Xiaohe Luo; Ying Ji; Jingwen Xie; Han Jiang; Mao Fu; Xiaoqiang Li
Journal:  Diabetes Res Clin Pract       Date:  2017-07-08       Impact factor: 5.602

3.  C1q/TNF-related protein 2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic triglyceride secretion.

Authors:  Xia Lei; G William Wong
Journal:  J Biol Chem       Date:  2019-08-22       Impact factor: 5.157

4.  Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions.

Authors:  G William Wong; Sarah A Krawczyk; Claire Kitidis-Mitrokostas; Tracy Revett; Ruth Gimeno; Harvey F Lodish
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

Review 5.  Metabolic function of the CTRP family of hormones.

Authors:  Marcus M Seldin; Stefanie Y Tan; G William Wong
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

Review 6.  Debates Regarding Lean Patients with Polycystic Ovary Syndrome: A Narrative Review.

Authors:  Manu Goyal; Ayman S Dawood
Journal:  J Hum Reprod Sci       Date:  2017 Jul-Sep

Review 7.  Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth.

Authors:  Joselyn Rojas; Mervin Chávez; Luis Olivar; Milagros Rojas; Jessenia Morillo; José Mejías; María Calvo; Valmore Bermúdez
Journal:  Int J Reprod Med       Date:  2014-01-28

8.  CTRP2 overexpression improves insulin and lipid tolerance in diet-induced obese mice.

Authors:  Jonathan M Peterson; Marcus M Seldin; Stefanie Y Tan; G William Wong
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 9.  Epidemiology, diagnosis, and management of polycystic ovary syndrome.

Authors:  Susan M Sirmans; Kristen A Pate
Journal:  Clin Epidemiol       Date:  2013-12-18       Impact factor: 4.790

10.  Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index.

Authors:  Melania Manco; Lidia Castagneto-Gissey; Eugenio Arrighi; Annamaria Carnicelli; Claudia Brufani; Rosa Luciano; Geltrude Mingrone
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more
  1 in total

Review 1.  Impact of Exercise and Aging on Mitochondrial Homeostasis in Skeletal Muscle: Roles of ROS and Epigenetics.

Authors:  Jialin Li; Zhe Wang; Can Li; Yu Song; Yan Wang; Hai Bo; Yong Zhang
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.